International conferences and seminars

6th Oncology Biomarkers

GTC is proud to present the 6th Oncology Biomarkers Conference as part of our Biomarker Summit 2013, to be held on March 20-22, 2013 in San Francisco, California. This conference will discuss a wide range of issues in the oncology biomarker field such as novel approaches to biomarker discovery, diagnostic and therapeutic development for cancer, utilization of next-generation sequencing in the clinic, regulatory and reimbursement trends and the development of companion diagnostics. These areas will be addressed in an intimate and highly interactive environment with perspectives from industry, academia and the public sector. Below is an agenda outline for this conference:

March 20th

Plenary Keynote Session

March 21st-22nd

Breakout: Oncology Biomarkers

Oncology Biomarker Discovery & Identification Strategies
Circulating / Body-Fluid Biomarkers
Diagnostics & Therapeutic Development for Cancer
Circulating/Body-Fluid Biomarkers in Oncology
Implementation of Next-generation Sequencing

Mar 22nd

General Session

Regulatory & Reimbursement Updates in Biomarker Development
+ Panel Discussion
New Technologies & Novel Approaches to Biomarker Development
Companion Diagnostics Development & Partnering Strategies
+ Panel Discussion

The 6th Oncology Biomarkers Conference will be running concurrently with the following tracks:

2nd Neurological Biomarkers
2nd Inflammatory & Immunological Biomarkers

Call for Papers!
To be considered for an oral presentation, please submit an abstract here by February 20, 2013. Selected presentations will be based on quality of abstract and availability. Presentation slots fill up fast so please submit your abstract ASAP.

Sponsorship and exhibiting opportunities are available in a range of levels, which can be tailored to fit your needs. Please contact 626-256-6405 x102 or spex@gtcbio.com for more information.

Best Regards,
Organizing Committee

See you in San Francisco!